Pharmaceutical products
Original title: Open-House-Originale-Rabattverträge 2026-11 - Apixaban
| Country | Germany |
|---|---|
| Deadline | 2028-09-30 (679 days left) |
| Published | 2026-08-19 |
| Sectors | Health & life sciences |
| Source | TED - Tenders Electronic Daily (EU) |
Summary
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Apixaban im Rahmen eines Open-House-Verfahrens.
The buyer, the value, the full description and the link to the official notice are available with a free account.